Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
CURE announced it has received their first purchase order from their recently announced agreement with Meroven for the development of OTF delivery for several molecules.
read more
Wednesday, March 13, 2019
CURE has broadened its DEA license as an authorized manufacturer of Schedule 1 substances to include both cannabis plant extracts and synthetic CBD.
read more
CURE Pharmaceutical has named Dr. Vered Gigi, Vice President of Strategy and Business Development.
read more
Curadev announced it has licensed its novel lead small molecule Stimulator of Interferon Genes (STING) agonist and associated patents to Takeda Pharmaceutical.
read more
Cumberland Pharmaceuticals has entered into an exclusive agreement with China's Winhealth Pharma Group for the licensing rights of Acetadote®.
read more
Thursday, September 17, 2015
Cumberland Pharmaceuticals, a specialty pharmaceutical company focused on hospital acute care and gastroenterology, has agreed to a strategic alliance with Clinigen Group plc, a global pharmaceutical and services company.
read more
CTK has launched two diagnostic tests for this virus, both a real time PCR based nucleic acid detection kit and a serological rapid screening test.
read more
Friday, December 08, 2017
CTI announced the acquisition of Eurotrials, a full-service contract research organization.
read more
Thursday, January 18, 2018
CTI BioPharma announced it expects to receive a $10 million milestone payment from Teva related to the achievement of a milestone for FDA approval of TRISENOX.
read more
CGT Catapult’s cell and gene therapy manufacturing center has been officially opened by the Business Secretary Greg Clark and Science Minister Sam Gyimah.
read more
Wednesday, February 22, 2012
NanoSonic Products, Inc., a wholly owned subsidiary of CTD Holdings, Inc., announced that the Company has signed a manufacturing agreement with Florida Biologix for the production of the sterile liquid form of its Trappsol Cyclo product, an orphan ...
read more
Wednesday, August 30, 2017
CSP Technologies is expanding its Auburn, Alabama manufacturing and warehousing capacity by 110,000 square feet.
read more
Tuesday, December 05, 2017
CSL and Vitaeris have entered into a collaboration and purchase option agreement to expedite the development of clazakizumab as a therapeutic option for solid organ transplant rejection.
read more
Tuesday, October 11, 2022
CSafe and BioLife Solutions, Inc. announced a new partnership to provide a combined global service network to support CGT products, with a focus on enhanced reliability, security and quality.
read more
Tuesday, February 17, 2026
CS Analytical has expanded its pharmaceutical testing services with the launch of Raw Material Analytical, adding raw material and finished product testing capabilities for pharmaceutical, biopharmaceutical, and related industries.
read more